Lupus pernio in sarcoidosis: Clinical features and treatment outcomes of 14 patients

Journal of Clinical Rheumatology

Volumn 9, Issue 2, 2003, Pages 72-76

  Yanardaǧ, Halil ^a   Pamuk, Ömer Nuri ^b   Pamuk, Gülsüm Emel ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

Corticosteroids; Cutaneous involvement; Lupus pernio; Sarcoidosis

Indexed keywords

CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; THALIDOMIDE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DRUG EFFECT; FEMALE; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; SKIN MANIFESTATION; STEROID THERAPY; TRANSBRONCHIAL BIOPSY; TREATMENT OUTCOME;

EID: 0038674668     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RHU.0000062509.01658.d1     Document Type: Article

References (22)

1. Scadding JG, Mitchell DN. Sarcoidosis of the skin. In: Scadding JG, Mitchell DN, eds. Sarcoidosis. London, England: Chapman&Hall Medical; 1985. p. 181-206.
2. Mana J, Marcoval J, Graells J, et al. Cutaneous involvement in sarcoidosis: relation to systemic disease. Arch Dermatol. 1997;133:882-888.
3. Elgart ML. Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol. 1986;4:35-45.
4. Spiteri MA, Matthey F, Gordon T, et al. Lupus pernio: a clinico-radiological study of thirty-five cases. Br J Dermatol. 1985;112:315-322.
5. James DG. Lupus pernio. Lupus. 1992;1:129-31.
6. De Remee RA. The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest. 1983;1:128-33.
7. Sharma OMP. Cutaneous sarcoidosis: clinical features and management. Chest. 1972;61:320-325.
8. James DG. Dermatological aspects of sarcoidosis. Q J Med. 1959;28:109-24.
9. Sulavik SB, Whitaker DL, Spencer RP. Lupus pernio: radiogallium imaging in a patient with chronic cutaneous sarcoidosis. Clin Nucl Med. 1994;19: 720-2.
10. Baughman RP, Judson MA, Teirstein AS, et al. Thalidomide for chronic sarcoidosis. Chest. 2002;122: 227-232.
11. Hunninghake GW, Gilbert S, Pueringer R. Outcome of the treatment of sarcoidosis. Am J Respir Crit Care Med. 1994;149:893-898.
12. Bersani TA, Nichols CW. Intralesional triamcinolone for cutaneous palpebral sarcoidosis. Am J Ophthalmol. 1985;99:561-562.
13. Zic JA, Horowitz DH, Arzubiaga C, et al. Treatment of cutaneous sarcoidosis with chloroquine. Arch Dermatol. 1991;127:1034-1040.
14. Webster GF, Razsi LK, Sanchez M, et al. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol. 1991;24:451-454.
15. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med. 1983;208:525-533.
16. Baughman RP, Lower EE. Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14:121-130.
17. Ziegenhagen MW, Benner UK, Zissel G, et al. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med. 1997;156: 1586-1592.
18. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18:70-74.
19. Goodman MM, Alpern K. Treatment of lupus pernio with the flashlamp pulsed dye laser. Lasers Surg Med. 1992;12:549-551.
20. Cliff S, Felix RH, Singh L, et al. The successful treatment of lupus pernio with the flashlamp pulsed dye laser. J Cutan Laser Ther. 1999;1:49-52.
21. Franceschini F, Calzavara-Pinton P, Valsecchi L, et al. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Adv Exp Med Biol. 1999;455:167-171.
22. Su WP, Perniciaro C, Rogers RS III, et al. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis. 1994;54:395-399.